Related Experiment Videos
[Aspergillosis with obstruction of the central airways]
Abstract:
Two cases are reported of obstruction of central airways by plugs containing Aspergillus fumigatus. In one case the obstruction was located in the right stem bronchus and, despite treatment with amphotericin B, the immunocompromised patient died from invasive disseminated aspergillosis. In the other case the obstruction was in the trachea and, since the immune function of the patient was normal, she responded favorably to treatment by amphotericin B.
Insights
Two cases of airway obstruction caused by Aspergillus fumigatus plugs are presented. Invasive aspergillosis led to death in an immunocompromised patient, while a patient with normal immunity recovered with amphotericin B treatment.
Area of Science:
- Medical Mycology
- Pulmonology
- Infectious Diseases
Background:
- Airway obstruction can be life-threatening, especially when caused by fungal infections.
- Aspergillus fumigatus is an opportunistic pathogen that can cause severe disease in susceptible individuals.
Observation:
- Two cases of central airway obstruction due to Aspergillus fumigatus plugs were identified.
- One case involved obstruction in the right stem bronchus of an immunocompromised patient.
- The second case involved tracheal obstruction in a patient with normal immune function.
Findings:
- The immunocompromised patient with a right stem bronchus obstruction died from invasive disseminated aspergillosis, despite amphotericin B treatment.
- The patient with normal immunity and tracheal obstruction showed a favorable response to amphotericin B treatment.
Implications:
- This highlights the critical role of immune status in the prognosis of Aspergillus fumigatus airway obstruction.
- Effective antifungal therapy, such as amphotericin B, is crucial but may be insufficient in severely immunocompromised patients.
- Early diagnosis and intervention are vital for managing fungal airway obstructions and improving patient outcomes.